These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19100106)

  • 1. [Systematic review on safety of intracoronary autologous bone marrow stem cells transfer in patients with acute myocardial infarction].
    Zhang SN; Sun AJ; Ge JB; Yao K; Huang ZY; Wang KQ; Zou YZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Aug; 36(8):679-84. PubMed ID: 19100106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of timing on efficacy and safetyof intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials.
    Zhang S; Sun A; Xu D; Yao K; Huang Z; Jin H; Wang K; Zou Y; Ge J
    Clin Cardiol; 2009 Aug; 32(8):458-66. PubMed ID: 19685520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: a meta-analysis of randomised controlled trials.
    Zhang SN; Sun AJ; Ge JB; Yao K; Huang ZY; Wang KQ; Zou YZ
    Int J Cardiol; 2009 Aug; 136(2):178-85. PubMed ID: 18644638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of timing on intracoronary autologous bone marrow-derived cell transplantation in acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Xu JY; Liu D; Zhong Y; Huang RC
    Stem Cell Res Ther; 2017 Oct; 8(1):231. PubMed ID: 29037256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.
    Janssens S; Dubois C; Bogaert J; Theunissen K; Deroose C; Desmet W; Kalantzi M; Herbots L; Sinnaeve P; Dens J; Maertens J; Rademakers F; Dymarkowski S; Gheysens O; Van Cleemput J; Bormans G; Nuyts J; Belmans A; Mortelmans L; Boogaerts M; Van de Werf F
    Lancet; 2006 Jan; 367(9505):113-21. PubMed ID: 16413875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials.
    Kang S; Yang YJ; Li CJ; Gao RL
    Coron Artery Dis; 2008 Aug; 19(5):327-35. PubMed ID: 18607170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beneficial effects of intracoronary autologous bone marrow stem cell transfer as an adjunct to percutaneous coronary intervention in patients with acute myocardial infarction.
    Wang X; Xi WC; Wang F
    Biotechnol Lett; 2014 Nov; 36(11):2163-8. PubMed ID: 24975729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intracoronary transfer autologous bone marrow stem cells can improve cardiac function in patients with left ventricular dysfunction after myocardial infarction].
    Nie Y; Guo YH; Guo LJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 39(6):634-7. PubMed ID: 18087557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.
    Wollert KC; Meyer GP; Lotz J; Ringes-Lichtenberg S; Lippolt P; Breidenbach C; Fichtner S; Korte T; Hornig B; Messinger D; Arseniev L; Hertenstein B; Ganser A; Drexler H
    Lancet; 2004 Jul 10-16; 364(9429):141-8. PubMed ID: 15246726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of intracoronary delivery of mononuclear bone marrow cells in patients with myocardial infarction: a two year follow-up results.
    Plewka M; Krzemińska-Pakuła M; Peruga JZ; Lipiec P; Kurpesa M; Wierzbowska-Drabik K; Korycka-Wołowiec A; Kasprzak JD
    Kardiol Pol; 2011; 69(12):1234-40. PubMed ID: 22219096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Marrow Mononuclear Cells Transfer for Patients after ST-Elevated Myocardial Infarction: A Meta-Analysis of Randomized Control Trials.
    Zhang J; Lin L; Zong W
    Yonsei Med J; 2018 Jul; 59(5):611-623. PubMed ID: 29869459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
    Hirsch A; Nijveldt R; van der Vleuten PA; Biemond BJ; Doevendans PA; van Rossum AC; Tijssen JG; Zijlstra F; Piek JJ;
    Am Heart J; 2006 Sep; 152(3):434-41. PubMed ID: 16923409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of rigorous study design in the research of autologous bone marrow-derived mononuclear cell transfer in patients with acute myocardial infarction.
    Jeong H; Yim HW; Cho Y; Park HJ; Jeong S; Kim HB; Hong W; Kim H
    Stem Cell Res Ther; 2013 Jul; 4(4):82. PubMed ID: 23849537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Observation on the safety: clinical trail on intracoronary autologous bone marrow mononuclear cells transplantation for acute myocardial infarction].
    Yao K; Huang RC; Ge L; Qian JY; Li YL; Xu SK; Zhang F; Zhang YQ; Niu YH; Shi JH; Zhang SH; Fan B; Wang QB; Sun AJ; Zou YZ; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):577-81. PubMed ID: 17081355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of selected bone marrow stem cells on left ventricular function in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Liu B; Duan CY; Luo CF; Ou CW; Sun K; Wu ZY; Huang H; Cheng CF; Li YP; Chen MS
    Int J Cardiol; 2014 Dec; 177(3):764-70. PubMed ID: 25465825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-Term Effect of Autologous Bone Marrow Stem Cells to Treat Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Clinical Trials.
    Cong XQ; Li Y; Zhao X; Dai YJ; Liu Y
    J Cardiovasc Transl Res; 2015 Jun; 8(4):221-31. PubMed ID: 25953677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of intracoronary autologous bone marrow-derived cell transplantation in patients with acute myocardial infarction: insights from randomized controlled trials with 12 or more months follow-up.
    Zhang C; Sun A; Zhang S; Yao K; Wu C; Fu M; Wang K; Zou Y; Ge J
    Clin Cardiol; 2010 Jun; 33(6):353-60. PubMed ID: 20556805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing for intracoronary administration of bone marrow mononuclear cells after acute ST-elevation myocardial infarction: a pilot study.
    Huang R; Yao K; Sun A; Qian J; Ge L; Zhang Y; Niu Y; Wang K; Zou Y; Ge J
    Stem Cell Res Ther; 2015 May; 6(1):112. PubMed ID: 26021558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.
    Assmus B; Leistner DM; Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Sedding D; Yu J; Corti R; Mathey DG; Barth C; Mayer-Wehrstein C; Burck I; Sueselbeck T; Dill T; Hamm CW; Tonn T; Dimmeler S; Zeiher AM;
    Eur Heart J; 2014 May; 35(19):1275-83. PubMed ID: 24569031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials.
    Zimmet H; Porapakkham P; Porapakkham P; Sata Y; Haas SJ; Itescu S; Forbes A; Krum H
    Eur J Heart Fail; 2012 Jan; 14(1):91-105. PubMed ID: 22065869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.